Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 917
Filtrar
1.
Bioorg Med Chem ; 101: 117637, 2024 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-38368633

RESUMO

Neural differentiation is triggered by the activation of multiple signaling pathways initiated by various neurotrophic factors. An elucidation of these mechanisms is anticipated to facilitate the prevention of diseases and the development of novel therapeutic approaches. Alternative small-molecule inducers for neuroscience studies are required instead of protein-based reagents for more efficient and convenient experiments. We demonstrated that small molecules of thieno[2,3-b]pyridine derivatives that induce neural differentiation, compounds 3a and 9a in particular, exhibited significant neuritogenic activity in rat pheochromocytoma (PC12) cells. Moreover, 3a displayed pronounced fluorescence and a discernible Stokes shift. Furthermore, the outcome of the experiment conducted on the NGF-insensitive clones of rat PC12 cells, and the results of the intercellular uptake analyses suggested that the 3a-mediated activation of neural differentiation occurred independently of the TrkA receptor. Therefore, 3a portrays potential applicability both as a small molecule reagent to replace novel neurotrophic factors and as a potent fluorescent reagent for various techniques, including bioimaging.


Assuntos
Fatores de Crescimento Neural , Quinolinas , Animais , Ratos , Diferenciação Celular/efeitos dos fármacos , Fator de Crescimento Neural/farmacologia , Fator de Crescimento Neural/metabolismo , Fatores de Crescimento Neural/metabolismo , Fatores de Crescimento Neural/farmacologia , Células PC12/efeitos dos fármacos , Fosforilação
2.
Ecotoxicol Environ Saf ; 269: 115786, 2024 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-38061083

RESUMO

Beauvericin (BEA), a naturally occurring cyclic peptide with good pharmacological activity, has been widely explored in anticancer research. Although BEA is toxic, studies have demonstrated its antioxidant activity. However, to date, the antioxidant mechanisms of BEA remain unclear. Herein, we conducted a comprehensive and detailed study of the antioxidant mechanism of BEA using an untargeted metabolomics approach, subsequently validating the results. BEA concentrations of 0.5 and 1 µM significantly inhibited H2O2-induced oxidative stress (OS), decreased reactive oxygen species levels in PC-12 cells, and restored the mitochondrial membrane potential. Untargeted metabolomics indicated that BEA was primarily involved in lipid-related metabolism, suggesting its role in resisting OS in PC-12 cells by participating in lipid metabolism. BEA combated OS damage by increasing phosphatidylcholine, phosphatidylethanolamine, and sphingolipid levels. In the current study, BEA upregulated proteins related to the PI3K/AKT/mTOR pathway, thereby promoting cell survival. These findings support the antioxidant activity of BEA at low concentrations, warranting further research into its pharmacological effects.


Assuntos
Antioxidantes , Apoptose , Depsipeptídeos , Metabolismo dos Lipídeos , Antioxidantes/farmacologia , Sobrevivência Celular , Depsipeptídeos/farmacologia , Peróxido de Hidrogênio/toxicidade , Metabolismo dos Lipídeos/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Fosfatidilinositol 3-Quinases , Proteínas Proto-Oncogênicas c-akt , Serina-Treonina Quinases TOR , Células PC12/efeitos dos fármacos , Células PC12/metabolismo , Animais , Ratos
3.
Toxins (Basel) ; 13(12)2021 12 10.
Artigo em Inglês | MEDLINE | ID: mdl-34941722

RESUMO

Venoms of solitary wasps are utilized for prey capture (insects and spiders), paralyzing them with a stinger injection to be offered as food for their larvae. Thus, the identification and characterization of the components of solitary wasp venoms can have biotechnological application. In the present study, the venom components profile of a solitary scoliid wasp, Campsomeriella annulata annulata, was investigated through a comprehensive analysis using LC-MS and -MS/MS. Online mass fingerprinting revealed that the venom extract contains 138 components, and MS/MS analysis identified 44 complete sequences of the peptide components. The peptides are broadly divided into two classes: bradykinin-related peptides, and linear α-helical peptides. Among the components of the first class, the two main peptides, α-campsomerin (PRLRRLTGLSPLR) and ß-campsomerin (PRLRRLTGLSPLRAP), had their biological activities evaluated. Both peptides had no effects on metallopeptidases [human neprilysin (NEP) and angiotensin-converting enzyme (ACE)] and acetylcholinesterase (AChE), and had no cytotoxic effects. Studies with PC12 neuronal cells showed that only α-campsomerin was able to enhance cell viability, while ß-campsomerin had no effect. It is noteworthy that the only difference between the primary structures from these peptides is the presence of the AP extension at the C-terminus of ß-campsomerin, compared to α-campsomerin. Among the linear α-helical peptides, annulatin (ISEALKSIIVG-NH2) was evaluated for its biological activities. Annulatin showed histamine releasing activity from mast cells and low hemolytic activity, but no antimicrobial activities against all microbes tested were observed. Thus, in addition to providing unprecedented information on the whole components, the three peptides selected for the study suggest that molecules present in solitary scoliid wasp venoms may have interesting biological activities.


Assuntos
Proteínas de Insetos/química , Proteínas de Insetos/toxicidade , Células PC12/efeitos dos fármacos , Fenômenos Toxicológicos/efeitos dos fármacos , Venenos de Vespas/química , Venenos de Vespas/toxicidade , Animais , Japão , Ratos
4.
Oxid Med Cell Longev ; 2021: 5598818, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34336105

RESUMO

Cicadae Periostracum (CPM), a commonly used animal traditional Chinese medicine (TCM), possesses antifebrile, spasmolytic, antiasthmatic, and antiphlogistic effects. In our present paper, we aimed to systemically investigate the antiepileptic effects of CPM in epileptic mice and explore the related molecular mechanism. Pentylenetetrazole- (PTZ) and strychnine-induced convulsion mice were established, and the results showed CPM could prolong the latency of convulsion and death and improve the neuronal damage in the hippocampus of PTZ-induced mice. Furthermore, the H2O2-treated PC12 cells were prepared to explore the possible mechanisms for the antiepileptic effects of CPM. CCK-8 results showed that CPM significantly improved the cell viability of H2O2-treated PC12 cells. Results of the acridine orange- (AO-) ethidium bromide (EB) staining, cell mitochondrial membrane potential (MOMP) analysis, and flow cytometry analysis showed that CPM significantly suppressed the H2O2-induced apoptosis in PC12 cells. In addition, CPM also downregulated the proapoptosis proteins, including Bax, cleaved- (C-) caspase-3, and C-caspase-9, and upregulated Bcl-2. Furthermore, CPM reduced the reactive oxygen species (ROS) levels via increasing antioxidative enzyme activities, including superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px). Importantly, CPM could increase the phosphorylation of phosphoinositide 3-kinase (PI3K) and protein kinase B (Akt) in H2O2-induced PC12 cells and can promote the nuclear transfer of the nuclear factor E2-related factor 2 (Nrf2) and increase the expression of heme oxygenase-1 (HO-1) in the cytoplasm. In conclusion, our present study suggested CPM possessed antiepileptic effects through antiapoptosis of neuron cells via regulation of the PI3K/Akt/Nrf2 signaling pathway.


Assuntos
Anticonvulsivantes/uso terapêutico , Apoptose/efeitos dos fármacos , Fator 2 Relacionado a NF-E2/metabolismo , Células PC12/efeitos dos fármacos , Fosfatidilinositol 3-Quinases/metabolismo , Animais , Anticonvulsivantes/farmacologia , Hemípteros , Insetos , Camundongos , Ratos , Transdução de Sinais
5.
World Neurosurg ; 147: e293-e305, 2021 03.
Artigo em Inglês | MEDLINE | ID: mdl-33340723

RESUMO

BACKGROUND: Long noncoding RNAs (lncRNAs) serve as crucial regulators in the pathogenesis of spinal cord injury (SCI). However, the role of lncRNA SOX2 overlapping transcript (SOX2OT) in SCI remains to be well revealed. METHODS: An SCI rat model was established and assessed by the Basso-Beattie-Bresnahan (BBB) method. An SCI PC12 cell model was established through lipopolysaccharide (LPS) treatment. Quantitative real-time polymerase chain reaction assay was used for SOX2OT, miR-331-3p, and neurogenic differentiation 1 (Neurod1) mRNA levels. Cell counting kit-8 assay and flow cytometry analysis were performed for cell viability and apoptosis, respectively. Enzyme-linked immunosorbent assay was performed for the levels of inflammatory cytokines. The production of superoxide dismutase and malondialdehyde was determined with relevant kits. Dual-luciferase reporter and RNA immunoprecipitation assays were conducted for the relationships among SOX2OT, miR-331-3p, and Neurod1. Western blot assay was employed for protein levels. RESULTS: SOX2OT was elevated in SCI rat and cell models. SOX2OT knockdown relieved the injury of SCI in SCI rat model. Moreover, the suppressive role in PC12 cell viability and the promotional roles in apoptosis, inflammation, and oxidative stress mediated by LPS were all restored by silencing SOX2OT. For mechanism analysis, SOX2OT was identified as a sponge of miR-331-3p to positively regulate Neurod1 expression. Inhibition of miR-331-3p reversed the effect of SOX2OT knockdown on LPS-induced PC12 damage. Overexpression of miR-331-3p protected PC12 cells from LPS-induced damage by binding to Neurod1. In addition, SOX2OT knockdown relieved PC12 cell injury by inactivation of Janus kinase-signal transducer and activator of transcription pathway. CONCLUSIONS: SOX2OT promoted PC12 cell injury through modulating miR-331-3p/Neurod1 axis and activating Janus kinase-signal transducer and activator of transcription pathway.


Assuntos
Fatores de Transcrição Hélice-Alça-Hélice Básicos/genética , Sobrevivência Celular/efeitos dos fármacos , Inflamação/genética , RNA Longo não Codificante/genética , Animais , Apoptose/genética , Sobrevivência Celular/genética , Inflamação/induzido quimicamente , Lipopolissacarídeos/farmacologia , Células PC12/efeitos dos fármacos , Ratos , Traumatismos da Medula Espinal/tratamento farmacológico , Traumatismos da Medula Espinal/metabolismo
6.
Neurotoxicology ; 82: 89-98, 2021 01.
Artigo em Inglês | MEDLINE | ID: mdl-33232743

RESUMO

We have previously shown that JM-20, a new chemical entity consisting of 1,5-benzodiazepine fused to a dihydropyridine moiety, protects against rotenone-induced neurotoxicity in an experimental model of Parkinson's disease (PD). The aim of this study was to investigate the effect of a novel hybrid molecule, named JM-20, in in vitro and in vivo models of PD induced by 6-hydroxydopamine (6-OHDA). PC-12 cells were exposed to 6-OHDA and treated with JM-20. Protection against mitochondrial damage induced by 6-OHDA was also investigated using isolated rat brain mitochondria. We found that JM-20 protected PC-12 cells against cytotoxicity induced by 6-OHDA and inhibited hydrogen peroxide generation, mitochondrial swelling and membrane potential dissipation. For in vivo experiments, adult male Wistar rats were lesioned in the substantia nigra pars compacta (SNpc) by 6-OHDA administration. JM-20 was orally administered (10, 20 or 40 mg/kg), intragastric via gavage, 24 h after surgery and daily for seven days. Treatment with JM-20 significantly reduced the percentage of motor asymmetry and increased vertical exploration. It improved the redox state of the SNpc and the striatal tissue of these animals. Also, JM-20 reduced glial fibrillary acidic protein overexpression and increased tyrosine hydroxylase-positive cell number, both in SNpc. Altogether, these results demonstrate that JM-20 is a potential neuroprotective agent against 6-OHDA-induced damage in both in vitro and in vivo models. The mechanism underlying JM-20 neuroprotection against 6-OHDA appears to be associated with the control of oxidative injury and mitochondrial impairment.


Assuntos
Antioxidantes/farmacologia , Benzodiazepinas/farmacologia , Encéfalo/efeitos dos fármacos , Mitocôndrias/efeitos dos fármacos , Fármacos Neuroprotetores/farmacologia , Niacina/análogos & derivados , Oxidopamina/toxicidade , Transtornos Parkinsonianos/tratamento farmacológico , Animais , Masculino , Mitocôndrias/metabolismo , Niacina/farmacologia , Teste de Campo Aberto/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Células PC12/efeitos dos fármacos , Transtornos Parkinsonianos/induzido quimicamente , Ratos , Ratos Wistar
7.
J Sep Sci ; 43(19): 3793-3805, 2020 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-32745365

RESUMO

Drug discovery from complex mixtures, like Chinese herbs, is challenging and extensive false positives make it difficult to obtain compounds with anti-Alzheimer's activity. In this study, a continuous method comprised of accelerated solvent extraction coupled with online two-dimensional countercurrent chromatography was developed for the efficient, scaled-up extraction and separation of six bioactive compounds from Citrus limon peels: neoeriocitrin, isonaringin, naringin, hesperidin, neohesperidin, and limonin. These active compounds were isolated and purified from the raw plant materials by two-dimensional countercurrent chromatography separation via two sets of an n-hexane/n-butanol/methanol/water solvent system: 0.23:1.00:0.25:1.13 and 0.47:1.00:0.38:1.46, v/v/v/v. The compounds were collected in yields of 0.22, 0.25, 0.10, 0.31, 0.29, and 0.28 mg/g, respectively, with purities of 95.79, 96.47, 97.69, 97.22, 98.11, and 98.82%, respectively. Subsequently, a simple and efficient in vitro method was developed for rapidly evaluating the acetylcholinesterase inhibitory activities of six bioactive components. Furthermore, the PC12 cell model and the in vitro metabolism of cytochromes P450 were employed to verify the monomers obtained from the continuous method. The results demonstrated that these six bioactive extracts from the C. limon peels were strong acetylcholinesterase inhibitors.


Assuntos
Citrus/química , Distribuição Contracorrente/métodos , Flavanonas/isolamento & purificação , Extratos Vegetais/química , Animais , Inibidores da Colinesterase/isolamento & purificação , Inibidores da Colinesterase/farmacologia , Sistema Enzimático do Citocromo P-450/efeitos dos fármacos , Sistema Enzimático do Citocromo P-450/metabolismo , Dissacarídeos/isolamento & purificação , Dissacarídeos/farmacologia , Flavanonas/farmacologia , Flavonoides/isolamento & purificação , Flavonoides/farmacologia , Hesperidina/análogos & derivados , Hesperidina/isolamento & purificação , Hesperidina/farmacologia , Células PC12/efeitos dos fármacos , Células PC12/metabolismo , Ratos , Solventes/química
8.
J Antibiot (Tokyo) ; 73(12): 859-862, 2020 12.
Artigo em Inglês | MEDLINE | ID: mdl-32647213

RESUMO

LC/MS-based chemical screening of culture extract led to a new highly oxygenated angucycline derivative, grecocycline D (1), from Streptomyces sp. KCB15JA014, isolated from a soil sample of Oedolgae in Jeju Island, Korea. The planar structure was determined on the basis of spectroscopic analysis, including 1D and 2D NMR techniques as well as HRESIMS and comparison with data from the literature. A relative and absolute configuration of 1 was assigned by ROESY experiment and electronic circular dichroism calculation. Compound 1 showed weak inhibitory activity against indoleamine 2,3-dioxygenase.


Assuntos
Antraquinonas/isolamento & purificação , Citotoxinas/isolamento & purificação , Streptomyces/química , Animais , Antraquinonas/química , Antraquinonas/farmacologia , Linhagem Celular/efeitos dos fármacos , Dicroísmo Circular , Citotoxinas/química , Citotoxinas/farmacologia , Cromatografia Gasosa-Espectrometria de Massas , Espectroscopia de Ressonância Magnética , Camundongos , Estrutura Molecular , Células PC12/efeitos dos fármacos , Ratos
9.
Sci Rep ; 10(1): 11631, 2020 07 15.
Artigo em Inglês | MEDLINE | ID: mdl-32669563

RESUMO

In this research, we prepared and formulated a neuroprotective supplement (copper nanoparticles in aqueous medium utilizing Crocus sativus L. Leaf aqueous extract) for determining its potential against methadone-induced cell death in PC12. The results of chemical characterization tests i.e., FE-SEM, FT-IR, XRD, EDX, TEM, and UV-Vis spectroscopy revealed that the study showed that copper nanoparticles were synthesized in the perfect way possible. In the TEM and FE-SEM images, the copper nanoparticles were in the mean size of 27.5 nm with the spherical shape. In the biological part of the present research, the Rat inflammatory cytokine assay kit was used to measure the concentrations of inflammatory cytokines. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) test was used to show DNA fragmentation and apoptosis. Caspase-3 activity was assessed by the caspase activity colorimetric assay kit and mitochondrial membrane potential was studied by Rhodamine123 fluorescence dye. Also, the cell viability of PC12 was measured by trypan blue assay. Copper nanoparticles-treated cell cutlers significantly (p ≤ 0.01) decreased the inflammatory cytokines concentrations, caspase-3 activity, and DNA fragmentation and they raised the cell viability and mitochondrial membrane potential in the high concentration of methadone-treated PC12 cells. The best result of neuroprotective properties was seen in the high dose of copper nanoparticles i.e., 4 µg. According to the above results, copper nanoparticles containing C. sativus leaf aqueous extract can be used in peripheral nervous system treatment as a neuroprotective promoter and central nervous system after approving in the clinical trial studies in humans.


Assuntos
Cobre/química , Crocus/química , Nanopartículas Metálicas/química , Metadona/toxicidade , Extratos Vegetais/farmacologia , Animais , Antioxidantes/farmacologia , Sobrevivência Celular/efeitos dos fármacos , Citocinas/metabolismo , Ensaios de Seleção de Medicamentos Antitumorais , Inflamação , Concentração Inibidora 50 , Potencial da Membrana Mitocondrial , Microscopia Eletrônica de Varredura , Microscopia Eletrônica de Transmissão , Células PC12/efeitos dos fármacos , Folhas de Planta/química , Ratos , Espectrofotometria Ultravioleta , Espectroscopia de Infravermelho com Transformada de Fourier , Difração de Raios X
10.
Food Funct ; 11(5): 4707-4718, 2020 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-32409814

RESUMO

Ferulic acid (FA) has been shown to have a neuroprotective effect on Alzheimer's disease induced by amyloid-beta (Aß) neurotoxicity. This work aims to ascertain the structure-activity relationship of FA and its alkyl esters (FAEs) for evaluating the antioxidant activities in PC12 cells and Aß1-42 aggregation inhibitory activities in vitro, as well as the signaling mechanisms against oxidative stress elicited by Aß1-42 in PC12 cells. Our data showed that alterations in the subcellular localization and cytotoxicity of FAEs caused by the lipophilicity of FA were crucial when evaluating their antioxidant capacities. Pre-treating cells with butyl ferulate (FAC4) significantly attenuated Aß1-42-evoked intracellular ROS formation. Besides, FAC4 exhibited the highest Aß1-42 aggregation inhibitory effectiveness. The molecular docking results showed that FAC4 binds to amide NH in Gln15 and Lys16 via a hydrogen bond. Notably, FAC4 could upregulate antioxidant defense systems by modulating the Keap1-Nrf2-ARE signaling pathway. Identification of the functions of FAEs could be useful in developing food supplements or drugs for treating AD.


Assuntos
Doença de Alzheimer/tratamento farmacológico , Peptídeos beta-Amiloides/efeitos dos fármacos , Ácidos Cumáricos/uso terapêutico , Fármacos Neuroprotetores/uso terapêutico , Peptídeos beta-Amiloides/metabolismo , Animais , Ácidos Cumáricos/administração & dosagem , Ácidos Cumáricos/farmacologia , Humanos , Simulação de Acoplamento Molecular , Fator 2 Relacionado a NF-E2/metabolismo , Fármacos Neuroprotetores/administração & dosagem , Fármacos Neuroprotetores/farmacologia , Estresse Oxidativo/efeitos dos fármacos , Células PC12/efeitos dos fármacos , Células PC12/metabolismo , Ratos
11.
Int J Mol Sci ; 21(7)2020 Apr 04.
Artigo em Inglês | MEDLINE | ID: mdl-32260390

RESUMO

The rhizome of Anemarrhena asphodeloides Bunge, used in Traditional Chinese Medicine as a brain function-improving herb, is a promising source of neuroprotective substances. The aim of this study was to evaluate the protective action of xanthones from A. asphodeloides rhizomes on the PC12 cell line exposed to the neurotoxic agent-3-nitropropionic acid (3-NP). The xanthone-enriched fraction of the ethanolic extract of A. asphodeloides (abbreviated from now on as XF, for the Xanthone Fraction), rich in polyphenolic xanthone glycosides, in concentrations from 5 to 100 µg/mL, and 3-NP in concentrations from 2.5 to 15 mM, were examined. After 8, 16, 24, 48, and 72 h of exposure of cells to various combinations of 3-NP and XF, the MTT viability assay was performed and morphological changes were estimated by confocal fluorescence microscopy. The obtained results showed a significant increase in the number of cells surviving after treatment with XF with exposure to neurotoxic 3-NP and decreased morphological changes in PC12 cells in a dose and time dependent manner. The most effective protective action was observed when PC12 cells were pre-incubated with the XF. This effect may contribute to the traditional indications of this herb for neurological and cognitive complaints. However, a significant cytotoxicity observed at higher XF concentrations (over 10 µg/mL) and longer incubation time (48 h) requires caution in future research and thorough investigation into potential adverse effects.


Assuntos
Anemarrhena/química , Fármacos Neuroprotetores/farmacologia , Nitrocompostos/efeitos adversos , Células PC12/citologia , Propionatos/efeitos adversos , Xantonas/farmacologia , Animais , Apoptose/efeitos dos fármacos , Relação Dose-Resposta a Droga , Medicamentos de Ervas Chinesas/química , Medicamentos de Ervas Chinesas/farmacologia , Estrutura Molecular , Fármacos Neuroprotetores/química , Células PC12/efeitos dos fármacos , Ratos , Rizoma/química , Fatores de Tempo , Xantonas/química
12.
Sci Rep ; 10(1): 1597, 2020 01 31.
Artigo em Inglês | MEDLINE | ID: mdl-32005890

RESUMO

This study compared effects of five hypoxia-inducible factor (HIF) prolyl hydroxylases (PHD) inhibitors on PC12 cells and primary rat neurons following oxygen-glucose deprivation (OGD). At 100 µM, the PHD inhibitors did not cause cytotoxicity and apoptosis. MTT activity was only significantly reduced by FG4592 or Bayer 85-3934 in PC12 cells. The PHD inhibitors at 100 µM significantly increased the LC3-II/LC3-I expression ratio and downregulated p62 in PC12 cells, so did FG4592 (30 µM) and DMOG (100 µM) in neurons. HIF-1α was stabilised in PC12 cells by all the PHD inhibitors at 100 µM except for DMOG, which stabilised HIF-1α at 1 and 2 mM. In primary neurons, HIF-1α was stabilised by FG4592 (30 µM) and DMOG (100 µM). Pretreatment with the PHD inhibitors 24 hours followed by 24 hour reoxygenation prior to 6 hours OGD (0.3% O2) significantly reduced LDH release and increased MTT activity compared to vehicle (1% DMSO) pretreatment. In conclusion, the PHD inhibitors stabilise HIF-1α in normoxia, induce autophagy, and protect cells from a subsequent OGD insult. The new class of PHD inhibitors (FG4592, FG2216, GSK1278863, Bay85-3934) have the higher potency than DMOG. The interplay between autophagy, HIF stabilisation and neuroprotection in ischaemic stroke merits further investigation.


Assuntos
Autofagia/efeitos dos fármacos , Prolina Dioxigenases do Fator Induzível por Hipóxia/antagonistas & inibidores , Isquemia/tratamento farmacológico , Aminoácidos Dicarboxílicos/farmacologia , Animais , Barbitúricos/farmacologia , Citometria de Fluxo , Imunofluorescência , Expressão Gênica/efeitos dos fármacos , Glicina/análogos & derivados , Glicina/farmacologia , Subunidade alfa do Fator 1 Induzível por Hipóxia/metabolismo , Isquemia/metabolismo , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Células PC12/efeitos dos fármacos , Ratos , Reação em Cadeia da Polimerase em Tempo Real
13.
Nat Prod Res ; 34(11): 1521-1527, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-30445866

RESUMO

A new ester (1) and a terpenoid (2) were isolated from the dried whole plant of Disporopsis aspersa (HUA) ENGL. ex DIELS for the first time and their structures were elucidated, as well as their biological activities are described. The two compounds all showed good antifungal activities, especially furanone (2) exhibited better antifungal activity against Pseudoperonospora cubensis and Phytophthora infestans with EC50 value of 22.82, 18.90 µg/mL, respectively. Compound 1 exhibited a significant promotion on the neurite outgrowth in NGF-induced PC-12 cells, and moderate inhibition on the NO production induced by lipopolysaccharide (LPS) in BV-2 microglial cells.


Assuntos
Anti-Inflamatórios/isolamento & purificação , Antifúngicos/isolamento & purificação , Asparagaceae/química , Crescimento Neuronal/efeitos dos fármacos , Extratos Vegetais/farmacologia , Animais , Anti-Inflamatórios/farmacologia , Antifúngicos/farmacologia , Ésteres/isolamento & purificação , Ésteres/farmacologia , Microglia/efeitos dos fármacos , Óxido Nítrico/antagonistas & inibidores , Células PC12/efeitos dos fármacos , Células PC12/ultraestrutura , Phytophthora infestans/efeitos dos fármacos , Extratos Vegetais/química , Ratos , Terpenos/isolamento & purificação , Terpenos/farmacologia
14.
Nat Prod Res ; 34(22): 3212-3218, 2020 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-31135233

RESUMO

A new triterpenoid saponin (1), 3-O-[ß-D-glucopyranosyl(1→6)]-(2'-angeloyl)-ß-D-glucopyranosyl-28-O-ß-D-glucopyranosyl(1→6)[α-L-rhamnopyranosyl(1→2)-ß-D-glucopyranosyl]-21-O-acetyl-16-deoxybarringtogenol C, together with four known saponins (2 ∼ 5) were isolated from the husks of Xanthoceras sorbifolium Bunge. Their structures were characterized by HR-ESI-MS, 1D-NMR, 2D-NMR spectra and chemical methods. Compound 1 exhibited excellent neuroprotection on PC12 cells injury induced by Aß25-35 at the doses of 150 µmol/L and 200 µmol/L. The cell viabilities were (76.18 ± 2.09) % and (76.02 ± 3.20) %, respectively.[Formula: see text].


Assuntos
Peptídeos beta-Amiloides/toxicidade , Fármacos Neuroprotetores/química , Fármacos Neuroprotetores/farmacologia , Fragmentos de Peptídeos/toxicidade , Sapindaceae/química , Animais , Sobrevivência Celular/efeitos dos fármacos , Espectroscopia de Ressonância Magnética , Estrutura Molecular , Fármacos Neuroprotetores/isolamento & purificação , Nozes/química , Ácido Oleanólico/análogos & derivados , Ácido Oleanólico/química , Células PC12/efeitos dos fármacos , Ratos , Saponinas/química , Espectrometria de Massas por Ionização por Electrospray , Triterpenos/química , Triterpenos/farmacologia
15.
J Med Food ; 22(12): 1226-1234, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31545135

RESUMO

Ischemic stroke is a major cause of disability and mortality globally. Although thrombolytic therapy is routinely adopted in cases of ischemic stroke, various alternative natural neuroprotectants are also used as effective adjuvant therapies to recover neurofunction following ischemic stroke. Raffinee, a natural fermented product with strong antioxidant and neuroprotective activities, has antiatherogenic effects in animals and has exhibited neuroprotective effects in a clinical trial by recovering motor and sensory function following spinal cord lesion. This study reveals the advantageous effects of Raffinee on PC12 cells by decreasing hypoxia-induced apoptosis in mice with permanent middle cerebral artery occlusion (pMCAO) by increasing the levels of neurotrophic factors such as S100ß, reducing serum inflammatory factors such as matrix metalloproteinases (MMP)-9/MMP-2 ratio, tumor necrosis factor-α, and interleukin (IL)-6 level, and increasing IL-10 levels. Significantly reduced brain infarct volume along with a favorable survival ratio was observed for pMCAO mice that received Raffinee, suggesting a neuroprotective potential of Raffinee in cases of acute ischemic stroke by suppressing apoptosis.


Assuntos
Alimentos Fermentados , Fármacos Neuroprotetores/metabolismo , Fármacos Neuroprotetores/farmacologia , Acidente Vascular Cerebral/tratamento farmacológico , Animais , Antioxidantes , Apoptose , Encéfalo , Citocinas/sangue , Citocinas/metabolismo , Modelos Animais de Doenças , Hipóxia , Infarto da Artéria Cerebral Média/tratamento farmacológico , Interleucina-10/sangue , Interleucina-10/metabolismo , Interleucina-6/sangue , Masculino , Metaloproteinase 2 da Matriz/sangue , Metaloproteinase 9 da Matriz/sangue , Camundongos , Camundongos Endogâmicos C57BL , Fatores de Crescimento Neural/metabolismo , Células PC12/efeitos dos fármacos , Ratos , Subunidade beta da Proteína Ligante de Cálcio S100/metabolismo , Taiwan , Fator de Necrose Tumoral alfa/sangue
16.
Neurotoxicology ; 75: 221-232, 2019 12.
Artigo em Inglês | MEDLINE | ID: mdl-31562916

RESUMO

This study aimed to explore effects and mechanisms of 004 (IMM-H004), a novel coumarin derivative, in OKA (okadaic acid)-induced AD (Alzheimer's disease)-like model. In vitro, MTT, LDH, and Annexin V/FITC flow cytometry assay were used to test cell survival. In vivo, OKA microinjection was conducted to simulate AD-like neuropathology. Morris water maze and Nissl staining were used to detect spatial memory function and neuronal damage respectively. Western blot and immunohistochemistry were used to study the mechanisms of 004 in Tau pathology. The results showed that 004 reduced cell death and increased survival in PC12 cells, and decreased neuronal injury in the hippocampus in rats. 004 improved learning and memory functions in OKA-treated rats. The mechanistic studies indicated that 004 inhibited phosphorylation of Tau protein by down-regulating the activity of protein kinases CDK5 and GSK3ß and increasing PP2A activity. Overall, 004 improved spatial memory impairments and neuron cells injury induced by OKA; on the other hand, 004 inhibited Tau hyperphosphorylation by regulating CDK5, GSK3ß and PP2A.


Assuntos
Cumarínicos/farmacologia , Fármacos Neuroprotetores/farmacologia , Ácido Okadáico/toxicidade , Proteínas tau/metabolismo , Doença de Alzheimer/tratamento farmacológico , Doença de Alzheimer/metabolismo , Animais , Apoptose/efeitos dos fármacos , Western Blotting , Modelos Animais de Doenças , Citometria de Fluxo , Masculino , Aprendizagem em Labirinto/efeitos dos fármacos , Ácido Okadáico/antagonistas & inibidores , Células PC12/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley
17.
Neurochem Int ; 129: 104498, 2019 10.
Artigo em Inglês | MEDLINE | ID: mdl-31278975

RESUMO

The present work aimed to explore the innovative hypothesis that different transcript/protein variants of a pro-neurotrophin may generate different biological outcomes in a cellular system. Nerve growth factor (NGF) is important in the development and progression of neurodegenerative and cancer conditions. Mature NGF (mNGF) originates from a precursor, proNGF, produced in mouse in two major variants, proNGF-A and proNGF-B. Different receptors bind mNGF and proNGF, generating neurotrophic or neurotoxic outcomes. It is known that dysregulation in the proNGF/mNGF ratio and in NGF-receptors expression affects brain homeostasis. To date, however, the specific roles of the two major proNGF variants remain unexplored. Here we attempted a first characterization of the possible differential effects of proNGF-A and proNGF-B on viability, differentiation and endogenous ngf gene expression in the PC12 cell line. We also investigated the differential involvement of NGF receptors in the actions of proNGF. We found that native mouse mNGF, proNGF-A and proNGF-B elicited different effects on PC12 cell survival and differentiation. Only mNGF and proNGF-A promoted neurotrophic responses when all NGF receptors are exposed at the cell surface. Tropomyosine receptor kinase A (TrkA) blockade inhibited cell differentiation, regardless of which NGF was added to culture media. Only proNGF-A exerted a pro-survival effect when TrkA was inhibited. Conversely, proNGF-B exerted differentiative effects when the p75 neurotrophin receptor (p75NTR) was antagonized. Stimulation with NGF variants differentially regulated the autocrine production of distinct proNgf mRNA. Overall, our findings suggest that mNGF and proNGF-A may elicit similar neurotrophic effects, not necessarily linked to activation of the same NGF-receptor, while the action of proNGF-B may be determined by the NGF-receptors balance. Thus, the proposed involvement of proNGF/NGF on the development and progression of neurodegenerative and tumor conditions may depend on the NGF-receptors balance, on specific NGF trancript expression and on the proNGF protein variant ratio.


Assuntos
Fator de Crescimento Neural/farmacologia , Células PC12/efeitos dos fármacos , Precursores de Proteínas/farmacologia , Animais , Diferenciação Celular/efeitos dos fármacos , Regulação da Expressão Gênica/efeitos dos fármacos , Masculino , Camundongos , Fatores de Crescimento Neural/biossíntese , Fatores de Crescimento Neural/genética , Proteínas do Tecido Nervoso , Isoformas de Proteínas/farmacologia , Precursores de Proteínas/biossíntese , Precursores de Proteínas/genética , Proteoma , RNA Mensageiro/biossíntese , RNA Mensageiro/genética , Ratos , Receptor trkA/antagonistas & inibidores , Receptores de Fatores de Crescimento , Receptores de Fator de Crescimento Neural/antagonistas & inibidores , Especificidade da Espécie
18.
Food Funct ; 10(7): 4143-4152, 2019 Jul 17.
Artigo em Inglês | MEDLINE | ID: mdl-31241085

RESUMO

Costunolide (COS) is a natural sesquiterpene lactone originally isolated from Inula helenium (Compositae). Although COS is known for its multiple pharmacological activities, neuroprotection of COS has not been fully elucidated. Increasing evidence demonstrates that oxidative stress is strongly associated with the progression and pathogenesis of neurodegenerative diseases. As NF-E2 related factor 2 (Nrf2) is an important transcription factor for the regulation of cellular redox homeostasis, small molecules with the ability to activate the Nrf2 pathway are promising neuroprotective agents. Herein, we investigated the potential mechanism of Nrf2-mediated neuroprotection against oxidative damage by COS in the neuron-like rat pheochromocytoma cell line (PC12 cells). Our results demonstrated that COS could activate Nrf2 to counteract the oxidative injuries of PC12 cells. COS facilitated the Nrf2 nuclear translocation, and knockdown of Nrf2 almost abrogated the cytoprotection of COS, demonstrating that activation of Nrf2 acted as an essential step in this cytoprotective process. After treatment with COS, a range of antioxidant genes governed by Nrf2 were upregulated, and subsequently the expressions and activities of these gene products were also induced. Furthermore, COS attenuates the cellular reactive oxygen species level and restores cellular thiol homeostasis, supporting that COS was involved in maintaining the cellular redox balance. Taken together, our study indicates that COS provides neuroprotection via activating the Nrf2 signaling pathway in PC12 cells.


Assuntos
Fator 2 Relacionado a NF-E2/efeitos dos fármacos , Fator 2 Relacionado a NF-E2/metabolismo , Fármacos Neuroprotetores/farmacologia , Células PC12/efeitos dos fármacos , Sesquiterpenos/farmacologia , Animais , Antioxidantes/metabolismo , Asteraceae/química , Citoproteção/efeitos dos fármacos , Homeostase/efeitos dos fármacos , Neuroproteção , Estresse Oxidativo/efeitos dos fármacos , Ratos , Transdução de Sinais/efeitos dos fármacos , Fatores de Transcrição/efeitos dos fármacos , Regulação para Cima/efeitos dos fármacos
19.
Toxicol Appl Pharmacol ; 379: 114639, 2019 09 15.
Artigo em Inglês | MEDLINE | ID: mdl-31251943

RESUMO

Sirtuin-3 (SIRT3) is a mitochondrial NAD + -dependent deacetylase that is essential in regulating mitochondrial proteins and maintaining cellular antioxidant properties. It has been reported that icariin (ICA) is neuroprotective over various neurotoxicant induced oxidative stress. This study aimed to determine whether ICA exerts neuroprotective effects on rotenone (ROT)-induced neurotoxicity through activation of SIRT3. Rats treated with ROT exhibited a marked loss of dopamine (DA) neurons and a decline in motor function, along with a decrease in protein expressions of SIRT3 and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) in the substantia nigra (SN). Administration of ICA significantly alleviated the loss of DA neurons, improved behavioral function, and concomitantly enhanced SIRT3 and PGC-1α expressions. The neuroprotective effect of ICA on ROT-induced cytotoxicity was further confirmed in the PC12 cell model, which showed significant improvement in the survival of ROT-treated cells with ICA pretreatment. The cytoprotective effect of ICA was abolished in ROT-treated cells by SIRT3 inhibitor 3-(1H-1,2,3-triazol-4-yl) pyridine (3-TYP), along with a resultant decrease in PGC-1α expression. In addition, knockdown of PGC-1α by siRNA suppressed ICA-mediated protective effects but did not affect SIRT3 expression, indicating the role of regulation of PGC-1α by SIRT3 in the protective action of ICA. Furthermore, we showed that ICA improved mitochondrial respiration, oxidative status, enhanced antioxidant enzyme SOD activity and GSH/GSSG ratio in cells treated with ROT. However, these protective effects of ICA on ROT-treated cells was markedly abolished by SIRT3 inhibitor 3-TYP. Our findings demonstrate that ICA exerts a neuroprotective role through upregulation of SIRT3.


Assuntos
Flavonoides/farmacologia , Glucosídeos/farmacologia , Fármacos Neuroprotetores/farmacologia , Síndromes Neurotóxicas/etiologia , Rotenona/toxicidade , Sirtuínas/metabolismo , Animais , Western Blotting , Neurônios Dopaminérgicos/efeitos dos fármacos , Neurônios Dopaminérgicos/patologia , Glutationa/metabolismo , Dissulfeto de Glutationa/metabolismo , Masculino , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/metabolismo , Síndromes Neurotóxicas/patologia , Síndromes Neurotóxicas/prevenção & controle , Estresse Oxidativo/efeitos dos fármacos , Consumo de Oxigênio/efeitos dos fármacos , Células PC12/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Espécies Reativas de Oxigênio/metabolismo , Teste de Desempenho do Rota-Rod , Rotenona/antagonistas & inibidores , Superóxido Dismutase/metabolismo
20.
Mol Med Rep ; 19(6): 4890-4896, 2019 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31059012

RESUMO

The aim of this study was to investigate the protective effect of sulforaphane (SFN) on 1­methyl­4­phenyl pyridine ion (MPP+)­induced cytotoxicity and to investigate its possible mechanisms. METHODS: PC12 cell toxicity induced by MPP+ served as a cell model of Parkinson's diseases. The cell culture + experiments were divided into four groups based on the different treatments, namely, vehicle control, SFN, MPP+ and SFN pretreatment plus MPP+. Cell viability and apoptosis were examined by MTT assay and flow cytometry, respectively. Expressions of nuclear factor erythroid 2­related factor 2 (Nrf2), heme oxygenase 1 (HO­1) and nicotinamide quinone oxidoreductase 1 (NQO1) were detected using western blotting. RESULTS: MPP+ reduced the survival rate of PC12 cells in a dose­ and time­dependent manner. After 24­h treatment with 500 µmol/l MPP+, the survival rate of PC12 cells decreased to 58.2±0.03% of that in the control groups. Under the same conditions MPP+ resulted in significant apoptosis of PC12 cells (apoptosis rate: 30.4±0.6%). However, SFN pretreatment significantly attenuated the cell damage induced by MPP+. Furthermore, it was demonstrated that SFN reversed the reduction of Nrf2, HO­1 and NQO1 expression induced by MPP+. CONCLUSION: SFN may protect PC12 cells from MPP+­induced damage via activating the Nrf2­ARE (antioxidant responsive element) pathway.


Assuntos
Isotiocianatos/farmacologia , Fator 2 Relacionado a NF-E2/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Células PC12/efeitos dos fármacos , Substâncias Protetoras/farmacologia , 1-Metil-4-fenilpiridínio/toxicidade , Animais , Elementos de Resposta Antioxidante , Antioxidantes/farmacologia , Antiparkinsonianos/farmacologia , Apoptose/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Heme Oxigenase-1/metabolismo , Isotiocianatos/administração & dosagem , NAD(P)H Desidrogenase (Quinona)/metabolismo , Doença de Parkinson/tratamento farmacológico , Ratos , Espécies Reativas de Oxigênio/metabolismo , Transdução de Sinais/efeitos dos fármacos , Sulfóxidos , Taxa de Sobrevida , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA